Bayer AG (BAYRY)
13.58
+0.08
(+0.59%)
USD |
OTCM |
Feb 13, 16:04
Bayer Free Cash Flow : 2.692B for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Merck KGaA | 369.40M |
| MediGene AG | -- |
| InflaRx NV | -47.11M |
| BioNTech SE | -588.89M |
| Immatics NV | -205.18M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 1.592B |
| Cash from Investing (Quarterly) | -1.314B |
| Cash from Financing (Quarterly) | 1.187B |
| Free Cash Flow Per Share (Quarterly) | 0.1568 |
| Free Cash Flow to Equity (Quarterly) | -851.02M |
| Free Cash Flow to Firm (Quarterly) | 1.353B |
| Free Cash Flow Yield | 5.04% |